Compare SRZN & WLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRZN | WLAC |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.3M | 184.9M |
| IPO Year | N/A | N/A |
| Metric | SRZN | WLAC |
|---|---|---|
| Price | $27.87 | $10.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $38.00 | $17.00 |
| AVG Volume (30 Days) | 67.1K | ★ 159.9K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $784.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.11 | $10.02 |
| 52 Week High | $29.99 | $15.19 |
| Indicator | SRZN | WLAC |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 38.52 |
| Support Level | $23.56 | $10.25 |
| Resistance Level | $28.78 | $11.22 |
| Average True Range (ATR) | 1.91 | 0.23 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 66.67 | 6.78 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Willow Lane Acquisition Corp is a blank check company.